Especialista en oftalmología Natalia Restrepo Galeano

Educación:

Pregrado: Universidad de Antioquia

Especialización: Universidad Pontificia Bolivariana

Miembro de:

Sociedad Colombiana de Oftalmología

Cómite Académico Clinica de Oftalmología Sandiego

Publicaciones que ha realizado:

• Nombre del evento ARVO 2010 Annual Meeting. The Future of Eye and Vision Research. May 2 – 6, 2010. Fort Lauderdale, Fl.  
  Poster session # 424.  Diabetic Retinopathy. Poster Presenter4233. Comparison of 2 doses of Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-upMonday, May 03, 2010, 8:30 AM - 8:45 AM
  Paper session # 220.  AMD Clinical Trial. Paper Co-Author1250. Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Subfoveal CNV in AMD: Results From the Pan-American Collaborative Retina Study Group at 24 MonthsMonday, May 03, 2010, 8:30 AM - 8:45 AM.
  
  
• Nombre del evento ARVO 2010 Annual Meeting. IX Annual Meeting Pan-American Research Day May 1, 2010. Fort Lauderdale, Fl.
  2010 Annual Meeting: Poster PresenterComparison of 2 doses of Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-upSaturday, May 01, 2010, 3:35 PM - 3:40 PM* Recipient of the 2010 Tyson ARVO Clinical Research Initiative Scholarship Award.
  
  
• Nombre del evento Joint Metting of the 29th PAAO Congress and the 113th AAO Annual Meeting Oct 24-27, 2009  San Franciso, CA
  2009 Joint Meeting: Poster Co-AuthorPO248 - Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Subfoveal CNV in AMD: Results From a Multicenter Study Group at 24 MonthsRoom: South, Hall A10/25/2009: 12:30 PM - 2:00 PM* 2009 Best Poster Award
   2009 Joint Meeting: Poster Co-AuthorPO261 – Bevacizumab IVT Primario para el Edema Macula Diabético Difuso: Resultados de un Grupo de Estudio Colaborativo de Retina a 24 MesesRoom: South, Hall A10/25/2009: 12:30 PM - 2:00 PM
  
  
• Nombre del evento V Congreso Internacional de Oftalmología Clofan 5 - 7 de agosto de 2009 Medellín, Colombia
  Paper Co-Author Bevacizumab IVT Primario para el Edema Macular Diabético Difuso: Resultados de un Grupo de Estudio Colaborativo de Retina a 24 MesesAgosto 07, 2009, 10:30 AM - 10:45 AM
  
  
• Nombre del evento ARVO 2009 Annual Meeting. Reducing Disparities in Eye Disease and Treatment. May 3 – 7, 2009 Fort Lauderdale, Fl
  Paper session # 250.  Diabetic Retinopathy III. Poster Co-Author1680. Comparison of 2 Doses of Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: Results From the Pan-American Collaborative Retina Study Group at 24 MonthsMonday, May 04, 2009, 3:00 PM - 3:15 PM
  
• Nombre del evento The 112th AAO Annual Meeting Subspecialty Day Retina. Nov 7 – 8, 2008 Atlanta – GA• 2008 Joint Meeting: Paper Co-AuthorAvastin in the Management of Diabetic Macular EdemaSection XII: Diabetic Retinopathy10/08/2008: 3:44 PM
  
  

Participación en congresos:

• Nombre del proyecto: Primary Intravitreal Bevacizumab for Diffuse Diabetic
  Macular Edema: The Pan-American Collaborative Retina
  Study Group at 24 Months
  Fecha de publicación Septiembre de 2009
  Título de la Revista Ophthalmology
  
  
• Nombre del proyecto Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in AMD at 24 Months: The Pan- American Collaborative Retina Study Group
  Fecha de aceptación Enero 28 de 2010 (Submission Ms. No. 2009-1328R2)
  Título de la Revista Ophthalmology

Otros estudios que ha realizado:

Certificada en Coaching Esencial